Maurizio Spinello

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.

Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.

Journal: Gynecologic oncology

Published: December 15, 2023

A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score.

A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score.

Journal: Frontiers in endocrinology

Published: July 26, 2021

Acromegaly can be cured by first-line pasireotide treatment?

Acromegaly can be cured by first-line pasireotide treatment?

Journal: Endocrine

Published: September 06, 2018

Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells.

Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells.

Journal: Endocrine

Published: November 30, 2016

ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease.

ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease.

Journal: Clinical endocrinology

Published: June 16, 2015

Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis.

Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 04, 2014

Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.

Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.

Journal: Journal of neuroendocrinology

Published: March 18, 2014

Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease.

Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease.

Journal: Pituitary

Published: February 01, 2014

Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.

Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.

Journal: Pituitary

Published: May 08, 2013

Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells.

Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells.

Journal: Molecular and cellular endocrinology

Published: May 21, 2012

Meta-analysis on the effects of octreotide on tumor mass in acromegaly.

Meta-analysis on the effects of octreotide on tumor mass in acromegaly.

Journal: PloS one

Published: December 23, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026